Herbas VPB

Print
EN | LT
LT - ENASIDENIB FOR USE IN THE TREATMENT OF RELAPSED OR REFRACTORY ACUTE MYELOID LEUKAEMIA
EN - ENASIDENIB FOR USE IN THE TREATMENT OF RELAPSED OR REFRACTORY ACUTE MYELOID LEUKAEMIA

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 45/06 (2013.01)
A61K 31/365 (2006.01)
A61K 31/404 (2006.01)
A61K 31/553 (2013.01)
A61K 31/53 (2013.01)
A61K 31/437 (2006.01)
A61K 31/551 (2013.01)
A61K 31/44 (2006.01)
A61K 31/5377 (2013.01)
A61K 31/444 (2006.01)
A61K 31/4709 (2006.01)
A61K 31/404 (2013.01)
A61K 31/496 (2006.01)
A61K 31/44 (2013.01)
A61K 31/497 (2006.01)
A61K 31/4709 (2013.01)
A61K 31/444 (2013.01)
A61K 31/5025 (2006.01)
A61K 31/365 (2013.01)
A61K 31/53 (2006.01)
A61K 31/497 (2013.01)
A61K 31/5377 (2006.01)
A61K 31/5025 (2013.01)
A61K 31/551 (2006.01)
A61K 31/496 (2013.01)
A61K 31/553 (2006.01)
A61K 31/437 (2013.01)
A61K 45/06 (2006.01)
C07D 251/52 (2013.01)
A61K 9/00 (2006.01)
C07D 403/14 (2013.01)
A61P 35/00 (2006.01)
C07D 401/14 (2013.01)
A61P 35/02 (2006.01)
A61P 35/02 (2018.01)
C07D 251/52 (2006.01)
C07D 401/14 (2006.01)
C07D 403/14 (2006.01)
European patent
(11) Number of the document 3419593
(13) Kind of document T
(96) European patent application number 16816810.2
Date of filing the European patent application 2016-12-02
(97) Date of publication of the European application 2019-01-02
(45) Date of publication and mention of the grant of the patent 2022-03-23
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2016/064615
Date 2016-12-02
PCT application publication
(87) Number WO 2017/146794
Date 2017-08-31
Priority applications
(30) Number Date Country code
201662300673 P 2016-02-26 US
Inventors
(72)
AMATANGELO, Michael , US
HU, Xiaolan , US
THAKURTA, Anjan , US
CHOE, Sung Eun , US
WU, Bin , US
Grantee
(73) Celgene Corporation , 86 Morris Avenue, Summit, NJ 07901, US
Les Laboratoires Servier , 50 rue Carnot, 92284 Suresnes Cedex, FR
Title
(54) ENASIDENIB FOR USE IN THE TREATMENT OF RELAPSED OR REFRACTORY ACUTE MYELOID LEUKAEMIA
  ENASIDENIB FOR USE IN THE TREATMENT OF RELAPSED OR REFRACTORY ACUTE MYELOID LEUKAEMIA